ATE539769T1 - Stabile pharmazeutische zusammensetzungen mit carvedilol - Google Patents

Stabile pharmazeutische zusammensetzungen mit carvedilol

Info

Publication number
ATE539769T1
ATE539769T1 AT09718156T AT09718156T ATE539769T1 AT E539769 T1 ATE539769 T1 AT E539769T1 AT 09718156 T AT09718156 T AT 09718156T AT 09718156 T AT09718156 T AT 09718156T AT E539769 T1 ATE539769 T1 AT E539769T1
Authority
AT
Austria
Prior art keywords
dosage form
carvedilol
pharmaceutically acceptable
acceptable salt
solid oral
Prior art date
Application number
AT09718156T
Other languages
English (en)
Inventor
Ashish Guha
Bharat Metkar
Makrand Avachat
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40917119&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE539769(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lupin Ltd filed Critical Lupin Ltd
Application granted granted Critical
Publication of ATE539769T1 publication Critical patent/ATE539769T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT09718156T 2008-03-04 2009-03-04 Stabile pharmazeutische zusammensetzungen mit carvedilol ATE539769T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN419KO2008 2008-03-04
PCT/IN2009/000147 WO2009110004A1 (en) 2008-03-04 2009-03-04 Stable pharmaceutical compositions qf carvedilol

Publications (1)

Publication Number Publication Date
ATE539769T1 true ATE539769T1 (de) 2012-01-15

Family

ID=40917119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09718156T ATE539769T1 (de) 2008-03-04 2009-03-04 Stabile pharmazeutische zusammensetzungen mit carvedilol

Country Status (4)

Country Link
US (1) US8889728B2 (de)
EP (1) EP2259801B1 (de)
AT (1) ATE539769T1 (de)
WO (1) WO2009110004A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI415604B (zh) * 2009-09-29 2013-11-21 Tsh Biopharm Corp Ltd 調控釋放卡菲蒂羅劑型
BR112014026250A2 (pt) 2013-01-15 2017-06-27 Fujifilm Corp preparação de produto sólido embalado contendo 5-hidroxi-1h-imidazola-4-carboxamida ou sal do mesmo, ou hidrato dos mesmos
MX2015009539A (es) 2013-03-14 2016-03-04 Thomas T Yamashita Composiciones para mejorar la polinizacion y metodos para usar las mismas.
WO2015126571A1 (en) 2014-02-24 2015-08-27 Yamashita Thomas T Fertilizer compositions comprising a cellulose nutrient component and methods for using same
KR102158339B1 (ko) * 2016-02-05 2020-09-21 삼진제약주식회사 인습성이 개선된 카르베딜롤 속방성 제제
US10772869B1 (en) 2019-07-24 2020-09-15 ECI Pharmaceuticals, LLC Pharmaceutical compositions including carvedilol and methods of using the same
US20240009094A1 (en) * 2022-07-11 2024-01-11 Honeywell International Inc. Anticaking composition and method for improving flowing properties of hygroscopic tin salts

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US3826358A (en) * 1972-05-10 1974-07-30 Miles Lab Package for tablets
US5018621A (en) * 1990-04-16 1991-05-28 Connell Jr John J O Cylindrical container and dispenser for spherical objects
US5114003A (en) * 1991-03-28 1992-05-19 E. I. Du Pont De Nemours And Company Tablet vial with desiccant in bottom
DE69910188T2 (de) 1998-04-09 2004-06-17 Roche Diagnostics Gmbh Arzneiformen enthaltend carvedilol
JP2003528914A (ja) * 2000-04-03 2003-09-30 エフ．ホフマン−ラ ロシュ アーゲー カルベジロールの濃縮溶液
US20010036959A1 (en) 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions
US6571942B2 (en) * 2001-08-09 2003-06-03 Multisorb Technologies, Inc. Container with integral material-treating container and method of fabrication thereof
WO2003024429A1 (en) 2001-09-21 2003-03-27 Egalet A/S Polymer release system
US20040019096A1 (en) 2001-10-23 2004-01-29 Vlassios Andronis Novel formulations of carvedilol
US7413083B2 (en) * 2002-04-11 2008-08-19 Csp Technologies, Inc. Desiccant vial assembly for effervescent tablets
US20050261335A1 (en) 2002-05-03 2005-11-24 Wei Chen Carvedilol formulations
US7871558B2 (en) * 2002-06-20 2011-01-18 Alcan Global Pharmaceutical Packaging, Inc. Containers intended for moisture-sensitive products
US8110260B2 (en) * 2007-02-02 2012-02-07 Rick Merical Containers intended for moisture-sensitive products
WO2008070072A2 (en) * 2006-12-01 2008-06-12 Mutual Pharmaceutical Company, Inc. Carvedilol forms, compositions, and methods of preparation thereof
WO2010027405A2 (en) * 2008-09-04 2010-03-11 Ironwood Pharmaceuticals, Inc. Stable solid formulations of gc-c receptor agonist polypeptides suitable for oral administration

Also Published As

Publication number Publication date
WO2009110004A1 (en) 2009-09-11
EP2259801B1 (de) 2012-01-04
EP2259801A1 (de) 2010-12-15
US20110005960A1 (en) 2011-01-13
US8889728B2 (en) 2014-11-18

Similar Documents

Publication Publication Date Title
ATE539769T1 (de) Stabile pharmazeutische zusammensetzungen mit carvedilol
CL2008003298A1 (es) Forma de dosificacion oral solida que comprende a) un compuesto de accion doble en concentracion entre 4 y 90%, b) un excipiente farmaceuticamente aceptable; proceso de preparación; uso en el tratamiento de enfermedades cardiovasculares y/o renales.
IL208832A (en) 3-Aminocarbazole Compound, Pharmaceutical Preparations Containing Them, Methods of Preparation and Use for Drug Preparation
UA97653C2 (ru) Мягкие капсулы, содержащие палоносетрона гидрохлорид, которые имеют улучшенную стабильность и биологическую доступность
CL2012000313A1 (es) Composición de dosificación de película que comprende una matriz portadora, entre 2-16 mg de buprenorfina, entre 0,5-5 mg de naloxona y un tampón que proporciona un ph local entre 2-4; procedimiento de preparación; uso en el tratamiento de la dependencia de narcóticos en un usuario.
CL2011000935A1 (es) Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor.
EP2120878A4 (de) Dosierform mit zwei oder mehr pharmazeutischen wirkstoffen in unterschiedlichen physikalischen formen
IL195294A (en) A process for the manufacture of high purity spinamide or relapinamide, their use in the preparation of medicaments and medicinal preparations containing them
ATE489078T1 (de) Pharmazeutische zusammensetzungen mit rosuvastatin-calcium
NO20045037L (no) Fremgangsmate for fremstilling av atorvastatin-kalsium i amorf form
IL195459A0 (en) Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
HK1164292A1 (en) Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
ATE489944T1 (de) Pharmazeutische feste zubereitung mit benzazepinen und herstellungsverfahren dafür
CL2012003012A1 (es) Composicion farmaceutica oral de liberacion prolongada que comprenden a) al menos un material de liberacion prolongada y b) hidromorfona o una sal y naloxona o una sal en una relacion 2:1 a 1:3; metodo de preparacion.
CL2007002921A1 (es) Forma solida de dosificacion farmaceutica de administracion oral, que comprende una forma cristalina o amorfa de un compuesto microincluido en un polimero ionico insoluble en agua en proporcion 5:1 a 1:5; y metodo de preparacion.
ATE400257T1 (de) Stabile pharmazeutische zusammensetzung mit linezolid form iv
CL2008001210A1 (es) Procedimiento para rellenar un producto en un envase que comprende: colocar un envase en un transportador de tablilla, trasladar la tablilla hacia una boquilla dispensadora, desplazar verticalmente la tablilla, manipular la tablilla en un grado de liberacion mientras se entrega el producto en el envase; sistema para rellenar.
EA201691869A1 (ru) Стабильная комбинированная фармацевтическая композиция
IL183163A0 (en) Sulfonamido-macrocycles as tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
ZA200701443B (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
IL199716A0 (en) Storage of ampoules containing pharmaceutical formulations using a sealed container comprising an oxygen scavenger
EA201071371A1 (ru) Упаковка для биологического материала
AR080256A1 (es) Formulaciones farmaceuticas solidas de ramipril y besilato de amlodipino y su preparacion
EA201190282A1 (ru) Фармацевтическая композиция, содержащая тамсулозин
ATE439125T1 (de) Fenofibrate tablett und verfahren zur herstellung